Net profit of TTK Healthcare rose 29.79% to Rs 16.73 crore in the quarter ended December 2024 as against Rs 12.89 crore during the previous quarter ended December 2023. Sales rose 11.36% to Rs 204.74 crore in the quarter ended December 2024 as against Rs 183.85 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales204.74183.85 11 OPM %3.752.90 - PBDT24.7021.01 18 PBT22.5917.70 28 NP16.7312.89 30 Powered by Capital Market - Live News

TTK Healthcare will hold a meeting of the Board of Directors of the Company on 24 January 2025.Powered by Capital Market - Live News

Net profit of TTK Healthcare rose 7.43% to Rs 17.20 crore in the quarter ended September 2024 as against Rs 16.01 crore during the previous quarter ended September 2023. Sales rose 6.85% to Rs 198.49 crore in the quarter ended September 2024 as against Rs 185.77 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales198.49185.77 7 OPM %4.155.14 - PBDT25.1924.84 1 PBT23.1921.56 8 NP17.2016.01 7 Powered by Capital Market - Live News

TTK Healthcare will hold a meeting of the Board of Directors of the Company on 25 October 2024.Powered by Capital Market - Live News

TTK Healthcare announced that Girish Rao (DIN: 00073937) and Dr (Mrs) Vandana R Walvekar (DIN: 00059160) have completed their second and final term as Independent Directors and consequently ceased to be the Directors of the Company w.e.f. 22 August 2024.Powered by Capital Market - Live News